Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Understand the dynamics of wealth building by comparing real estate and stocks. Find out which option may yield faster returns for your investments.
26,865 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
When Ringo Starr performed in San Diego, the night wasn’t just about nostalgia. The All Starr Band’s rotating lineup ...
SpaceX hit the market with a bang, as spacex stock climbed first in its debut week. This analysis looks at what histo...
Backlog in the commercial space economy just reached a pivotal $500 billion mark as SpaceX began trading on NASDAQ, s...
A big shift in Berkshire’s thinking could put Alphabet in the spotlight for investors. This deep dive explains what t...
A large hedge fund reduced its stake in InterDigital (IDCC) by selling 125,230 shares, worth about $44.28 million. Th...
In 2026, the global air fleet is being renewed around a handful of high-performance fighters. Investors are watching ...
Hedge-fund CIOs say the refining space offers persistent profit potential due to structural capacity limits, even as ...
Bitcoin holds near the $78,000 mark as on-chain indicators point to rising holder consolidation and shrinking availab...
NVIDIA posted a blowout quarter as AI demand drives data-center growth, fueling bets that the company will form trill...
Stocks extend an eight-week gain streak, signaling persistent momentum amid easing volatility. Here’s what traders ar...